May 19 (Thursday) 8:00-10:00 |
Room9(Kobe Portopia Hotel[Kairaku 3] Main Building B1F) |
NF-01 |
Next-generation neurogenetics: cutting-edge strategies for understanding neurological disorders |
Masashi Aoki (Department of Neurology, Tohoku University School of Medicine) / Yuji Takahashi (Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry) |
Yuji Takahashi (Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry) |
Impact of next-generation sequencing on deciphering ALS pathogenesis |
Matthew Harms (Department of Neurology, Columbia University/Institute for Genomic Medicine, Columbia University) |
The Genetics of Amyotrophic Lateral Sclerosis: Past Success, Current Challenges, Future Directions |
Naoki Atsuta (Department of Neurology, Nagoya University Hospital) |
Genetic aspects of sporadic ALS based on JaCALS cohort study |
Bing-Wen Soong (Medicine, Section of Neurology, National Yang-Ming University and Department of Neurology, Taipei Veterans General Hospital, Taipei, Taiwan) |
Next generation sequencing-based diagnoses of neurological disorders |
Wataru Satake (Div Neurol, Kobe Univ) |
Genetics-based approach for understanding Parkinson's disease |
May 21 (Saturday) 8:00-10:00 |
Room10(Kobe International Conference Center[Main Hall] B1F・1F) |
NF-02 |
Therapeutic strategies, mechanisms of spreading of α-synuclein, and biomarkers of Parkinson's disease |
Nobutaka Hattori (Department of Neurology, Juntendo University School of Medicine) / Hidefumi Ito (Department of Neurology, Wakayama Medical University) |
Seung-Jae Lee (Department of Biomedical Sciences, Seoul National University College of Medicine) |
Critical evaluation of the proteotoxin paradigm of neurodegenerative diseases |
Makio Takahashi (Department of Neurology, Japan Red Cross Osaka Hospital) |
Morphological and biological mechanisms of alpha-synuclein spreading in Parkinson's disease |
Shinji Saiki (Department of Neurology, Juntendo University Graduate School of Medicine) |
Blood biomarkers of Parkinson's disease |
May 18 (Wednesday) 13:15-15:15 |
Room8(Kobe Portopia Hotel[Kairaku 2] Main Building B1F) |
TN-02 Co-host: The Japan Neuroscience Society |
Current topics in myotonic dystrophy - advance in disease machanism and emerging clinical issues |
Masanori Takahashi (Department of Neurology, Osaka University Graduate School of Medicine) / Tohru Matsuura (Division of Neurology, Department of Medicine Jichi Medical University) |
Tetsuo Ashizawa (Methodist Hospital Research Institute) |
Myotonic dystrophy type 1 - potential pitfalls in therapeutic development |
Ruriko Kitao (Department of Neurology, Hakone Hospital) |
Newly identified Japanese DM2 pedigree |
Mitsuru Kawamura (Department of Neurology, Showa University School of Medicine) |
Social cognitive impairment in myotonic dystrophy type 1. |
Yasushi Iwasaki (Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University) |
Brain pathology of the myotonic dystrophy |
Kuang-Yung Lee (Department of Molecular Genetics and Microbiology, Center for NeuroGenetics and the Genetics Institute, University of Florida, College of Medicine, Gainesville, Florida, USA/Department of Neurology, Chang Gung Memorial Hospital, Keelung,Taiwan/School of Medicine, Chang Gung University, Taoyuan, Taiwan) |
Muscleblind-like double knockout mice for modeling myotonic dystrophy |
May 19 (Thursday) 8:00-10:00 |
Room2(Kobe International Exhibition Hall[Exhibition Hall A] Hall No.1 Building 2F) |
TN-04 |
Acute treatment and secondary prevention of stroke:The breaking evidences |
Yoshiaki Itoh (Dept Neurology, Osaka City University Graduate School of Medicine) / Haruhiko Hoshino (Department of Neurology, Tokyo Saiseikai Central Hospital) |
Shigeru Nogawa (Department of Neurology, Tokai University Hachioji Hospital) |
Medical treatment for acute ischemic stroke - IV t-PA in Japan and issues to be discussed |
Stephen Davis (University of Melbourne/Melbourne Brain Centre at Royal Melbourne Hospital) |
Endovascular therapy for acute ischemic stroke: future directions |
Naohisa Hosomi (Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical & Health Sciences) |
Management of Dyslipidemia for Stroke Prevention |
Teruyuki Hirano (Department of Stroke and Cerebrovascular Medicine, Kyorin University) |
Oral anticoagulant therapy for prevention of cardioembolism |
Room10(Kobe International Conference Center[Main Hall] B1F・1F) |
TN-05 |
Recent advance of Clinical trials and treatment in progressive supranuclear palsy |
Ikuko Aiba (Department of Neurology, National Hospital Organization, Higashi Nagoya National Hospital) / Kenji Nakashima (Division of Neurology, Department of Brain and Neurosciences Faculty of Medicine, Tottori University) |
Masato Kanazawa (Department of Neurology, Brain Research Institute, Niigata University) |
Broad phenotypic spectrum and symptomatic treatments of progressive supranuclear palsy |
Shunsuke Koga (Department of Neuroscience, Mayo Clinic) |
Clinicopathologic study on progressive supranuclear palsy with cerebellar ataxia in the US |
Hitoshi Shimada (Molecular Imaging Center, National Institute of Radiological Sciences) |
Current status and issues of clinical application of tau PET in progressive supranuclear palsy |
Adam L. Boxer (University of California, San Francisco) |
Targeting Tauopathies for Tau Therapeutic Translation |
May 19 (Thursday) 15:15-17:15 |
Room10(Kobe International Conference Center[Main Hall] B1F・1F) |
TN-06 |
Improvement in the management of Parkinson's disease: Present status and prospect of ultra-early diagnosis |
Kazushi Takahashi (Department of Neurology, Saitama Medical University) / Hirohisa Watanabe (Nagoya University, Brain and Mind Research Center) |
David J. Burn (Institute of Neuroscience, Newcastle University) |
Diagnosing Parkinson disease. When and how. |
Eng-King Tan (National Neuroscience Institute/Duke NUS Graduate Medical School) |
Motor and non motor features of prodromal & early stage genetic forms of Parkinson disease |
Satoshi Orimo (Department of Neurology, Kanto Central Hospital) |
Nuclear neuroimaging: Potential diagnostic value of SPECT and PET |
Epifanio Bagarinao (Brain and Mind Research Center, Nagoya University) |
Novel neuroimaging approaches for exploring cerebral functional and anatomical connectivity |
May 18 (Wednesday) 9:50-11:50 |
Room4(Kobe International Exhibition Hall[Room 3A] Hall No.2 Building 3F) |
HT-02 |
Myasthenia gravis: New insights and overview |
Naoko Matsui (Department of Neurology, Tokushima University Hospital) / Tomihiro Imai (Sapporo Medical University School of Health Sciences) |
Tomihiro Imai (Sapporo Medical University School of Health Sciences) |
Perspective in the study of Japanese Clinical Guideline and overview |
Hiroaki Yoshikawa (Kanazawa University Health Service Center) |
Thymectomy in Non-thymomatous Myasthenia Gravis: MGTX study a Randomized, Controlled Trial |
Akiyuki Uzawa (Department of Neurology, Graduate School of Medicine, Chiba University) |
Inflammatory Markers of Myasthenia Gravis |
Alexander Marx (University of Heidelberg) |
Intrathymic pathogenesis in various Myasthenia Gravis (MG) subgroups |
Naoko Matsui (Department of Neurology, Tokushima University Hospital) |
Approach from T cell development in MG thymus |
Room5(Kobe International Exhibition Hall[Room 2A] Hall No.2 Building 3F) |
HT-03 |
Cutting edge of metabolic/hereditary neuropathies |
Satoshi Kuwabara (Department of Neurology, Chiba University) / Haruki Koike (Department of Neurology, Nagoya University Graduate School of Medicine) |
Yoshiki Sekijima (Department of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine) |
Cutting-edge therapies for amyloid neuropathy |
Masanori Nakagawa (North Medical Center, Kyoto Prefectural University of Medicine) |
Therapeutic strategy for Charcot-Marie-Tooth disease |
Sonoko Misawa (Department of Neurology, Graduate School of Medicine, Chiba University) |
Current therapeutic strategies for POEMS syndrome |
Susanna B. Park (Brain and Mind Centre, University of Sydney) |
Chemotherapy-induced Peripheral Neuropathy: From Pathophysiology to Neuroprotection |
May 19 (Thursday) 8:00-10:00 |
Room14(Kobe International Conference Center[Meeting Room 501] 5F) |
HT-06 |
Neuroregeneration and nucleic acid medicine |
Hideyuki Okano (Keio University School of Medicine Department of Physiology) / Masayuki Nakamori (Dept. of Neurology, Osaka University Graduate School of Medicine) |
Frank Bennett (IONIS Pharmaceuticals) |
Antisense Oligonucleotide Therapies for the Treatment of Neurodegenerative Diseases |
Kazutaka Nishina (Department of Neurology and Neurological Science, Graduate School, Tokyo Medical and Dental University) |
Novel oligonucleotide based on DNA/RNA heteroduplex structures |
Dong-ki Lee (Department of Chemistry, Sungkyunkwan University) |
Therapeutic development using cell penetrating, asymmetric RNAi triggers |
Kazunobu Sawamoto (Department of Developmental and Regenerative Biology, Nagoya City University Graduate School of Medical Sciences) |
Migration and maturation of new neurons in the normal and injured adult brain |
Seiji Hitoshi (Department of Integrative Physiology, Shiga University of Medical Science) |
The role of adult neural stem cell-neurogenesis in the pathogenesis of psychiatric disorders |
Tatsunori Seki (Department of Histology and Neuroanatomy, Tokyo Medical University) |
Unique embryonic neurogenesis in the hippocampus, an adult neurogenic region |
May 19 (Thursday) 15:15-17:15 |
Room6(Kobe International Exhibition Hall[Room 3B] Hall No.2 Building 3F) |
HT-08 |
Molecular dissection of Hereditary Spastic Paraplegia |
Toshitaka Kawarai (Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan) / Hiroyuki Ishiura (Department of Neurology, The University of Tokyo) |
Craig Blackstone (NINDS, US National Institutes of Health) |
Emerging genetic and cellular insights into HSP pathogenesis |
Kishin Koh (Department of Neurology, University of Yamanashi) |
Molecular epidemiology of HSPs in Japan |
Chin-Song Lu (Chang Gung Medical Center at Linkou and Chang Gung University) |
Genetic Analysis in a Cohort of Taiwanese Patients with Hereditary Spastic Paraplegia |
Hiroyuki Ishiura (Department of Neurology, The University of Tokyo) |
Strategies for identifying causative genes of HSP |
Toshitaka Kawarai (Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan) |
A Homozygous loss-of-function mutation in DNAJA3 causes HMSN type V |
May 19 (Thursday) 15:15-16:55 |
Room15(Kobe International Conference Center[Meeting Room502] 5F) |
HT-09 |
Combining imaging and therapy: Neuroimaging-based companion diagnostics and theranostics |
Makoto Higuchi (Molecular Imaging Center, National Institute Radiological Sciences) / Makoto Yoneda (Faculty of Nursing and Social Welfare Sciences Fukui Prefectural University) |
Shin-ichi Muramatsu (Division of Neurology, Jichi Medical University/Center for Gene & Cell Therapy, The Institute of Medical Science, The University of Tokyo) |
In vivo monitoring of AADC gene delivery by PET |
Michael D. Devous (Vice President, Avid Radiopharmaceuticals, Inc.) |
The Role of Amyloid and Tau Imaging in Clinical Trials in Alzheimer's Disease |
Masahiro Mishina (Department of Neuro-pathophysiological imaging, Graduate School of Medicine, Nippon Medical School/Research Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology) |
Imaging and treatment targeting adenosine receptors in Parkinson's disease |
Bin Ji (National Institute of Radiological Sciences) |
In vivo Imaging for Monitoring Differentiation and Manipulating Function of iPS Cells |
May 20 (Friday) 8:00-10:00 |
Room8(Kobe Portopia Hotel[Kairaku 2] Main Building B1F) |
HT-12 Co-host: Asian Pacific Society of Prion Research |
Expanding prion concept to cerebral beta-amyloidosis and alpha-synucleinopathies |
Masahito Yamada (Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences) / Takeshi Iwatsubo (Department of Neuropathology Graduate School of Medicine The University of Tokyo) |
Atsushi Kobayashi (Graduate School of Veterinary Medicine, Hokkaido University) |
Mechanisms of transmission of prion diseases |
Mathias Jucker (Hertie Institute for Clinical Brain Research, University of Tübingen, Germany/German Center for Neurodegenerative Diseases, Tübingen, Germany) |
Propagation and spreading of Alzheimer lesions |
Tsuyoshi Hamaguchi (Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Science) |
Possible iatrogenic transmission of cerebral beta-amyloidosis |
Seung-Jae Lee (Department of Biomedical Sciences, Seoul National University College of Medicine) |
Progression mechanism of synucleinopathies |
Room13(Kobe International Conference Center[Meeting Rooms 401+402] 4F) |
HT-13 |
Understanding ALS pathogenesis by Updated progress in C9ORF72-TDP43 lineage |
Takanori Yokota (Department of Neurology and Neurological Science, Tokyo Medical and Dental University) / Makoto Urushitani (Department of Neurology, Kyoto University Graduate School of Medicine) |
Hitoshi Takahashi (Department of Pathology, Brain Research Institute, Niigata University) |
Amyotrophic lateral sclerosis and C9ORF72/TDP-43 pathology |
Suzuki Naoki (Department of Neurology, Tohoku University/Department of Stem Cell and Regenerative Biology, Harvard University) |
Deciphering the expression and function of C9ORF72 using mouse model |
Yoshitsugu Aoki (Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry) |
C9orf72-Rab mediates defective vesicle trafficking in C9ALS/FTD and rescue by antisense intervention |
Makoto Urushitani (Department of Neurology, Kyoto Graduate School of Medicine) |
Impaired VHL/CUL2-mediated clearance of misfolded TDP-43 underlies oligodendrocyte inclusions in ALS |
Leonard Petrucelli (Mayo Clinic) |
(TBA) |
May 20 (Friday) 13:15-14:55 |
Room8(Kobe Portopia Hotel[Kairaku 2] Main Building B1F) |
HT-15 |
Gene therapy & regenerative medicine |
Hideki Mochizuki (Department of Neurology, Osaka University Graduate School of Medicine) / Haruhisa Inoue (Center for IPS Cell Research and Application, Dept.of Cell Growth and Differentiation) |
Krystof Bankiewicz (Neurosurgery and Neurology, University of California San Francisco, CA, USA) |
MRI-based Platform for AAV2-GDNF and AAV-2AADC Gene Delivery in Parkinson's disease. |
Jun Takahashi (Kyoto University, Center for iPS Cell Research and Application) |
Cell-Based Therapeutics for Parkinson's disease |
Masayuki Nakamori (Dept. of Neurology, Osaka University Graduate School of Medicine) |
Gene therapy with antisense oligonucleotides for neurological and neuromuscular disorders |
Ryoichiro Kageyama (Kyoto University, Institute for Virus Research/Kyoto University, WPI-iCeMS) |
Oscillatory control of proliferation and differentiation of neural stem cells |
May 20 (Friday) 13:15-15:15 |
Room10(Kobe International Conference Center[Main Hall] B1F・1F) |
HT-17 |
Translational approach for prevention and treatment of MS |
Takashi Yamamura (Department of Immunology, National Institute of Neuroscience, NCNP) / Takayuki Kondo (Department of Clinical Network and Collaborative Medicine Kyoto University) |
Ralf Gold (Department of Neurology, St. Josef-Hospital/Ruhr-University Bochum) |
IMPACT OF NUTRITION ON CNS AUTOIMMUNITY AND THEIR THERAPEUTIC POTENTIAL FOR MULTIPLE SCLEROSIS |
Sachiko Miyake (Department of Immunology,Juntendo University School of Medicine) |
Alterations in gut flora giving clues to the cure of MS |
Daisuke Noto (Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP)/Department of Immunology, Juntendo University Graduate School of Medicine) |
Investigator-Initiated Clinical Trial (first-in-human, Phase I) of invariant NKT cell ligand OCH |
Ho Jin Kim (Department of Neurology, National Cancer Center, Korea) |
Current and future treatment for multiple sclerosis |
Masakazu Nakamura (Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan/Department of Neurology, Hokkaido Medical Center, Sapporo, Japan) |
IL-6 signal blockade for CNS autoimmune diseases |
May 19 (Thursday) 8:00-10:00 |
Room11(Kobe International Conference Center[International Conference Hall] 3・4F) |
AI-01 |
Hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P) in Asia |
Toshitaka Kawarai (Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University Graduate School) / Elahe Elahi (Department of Biotechnology, College of Science, University of Tehran) |
Toshitaka Kawarai (Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima city, Japan) |
Clinicopathological features of HMSN-P in the Kansai area of Japan |
Masahito Suehara (Neurology, Fujimoto General Hospital of Fujimoto Medical System) |
HMSN-P in the Okinawa islands of Japan; clinical-epidemiological-neurophysiological findings |
Byung-ok Choi (Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine) |
Proximal dominant hereditary motor and sensory neuropathy in Korean patients with TFG mutation |
Elahi Elahe (College of Science, University of Tehran) |
Iranian patients affected with familial forms of neuromuscular disorders with mutations in TFG |
Ryosuke Oki (Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan) |
Animal model of HMSN-P |
Nagahisa Murakami (Center for iPS Cell Research and Application (CiRA), Kyoto University/Department of Clinical Neuroscience, Institute of Health Biosciences, Tokushima University Graduate School) |
Modeling HMSN-P motor neurons using patient iPSCs with mutant TFG |
May 19 (Thursday) 15:15-17:15 |
Room11(Kobe International Conference Center[International Conference Hall] 3・4F) |
AI-02 |
X-linked Dystonia Parkinsonism |
Lillian V. Lee (Philippine Children's Medical Center) / Tatsushi Toda (Division of Neurology Kobe University Graduate School of Medicine) |
Lillian V. Lee (Philippine Children's Medical Center) |
Clinical Picture of X-Linked Dystonia Parkinsonism (XDP) |
David Eidelberg (The Feinstein Institute for Medical Research) |
Abnormal visual motion perception pathways in primary dystonia |
Ryosuke Miyamoto (Department of Neurology, Tokushima University Hospital) |
Genetics of X-linked Dystonia Parkinsonism |
Ryoma Morigaki (Parkinson's Disease and Dystonia Research Center, Tokushima University Hospital/Department of Neurosurgery, Institute of Biomedical Sciences, Graduate School of Medical Sciences, Tokushima University) |
Neuropathology of X-linked dystonia parkinsonism |
Tatsushi Toda (Division of Neurology / Molecular Brain Science Kobe University Graduate School of Medicine) |
Gene Therapy for Transposon Disease |
May 18 (Wednesday) 13:15-15:15 |
Room11(Kobe International Conference Center[International Conference Hall] 3・4F) |
S-03 |
Movement disorders update |
Kazuko Hasegawa (Department of Neurology, National Hospital Organization, Sagamihara National Hospital) / Takashi Sakamoto (Department of Neurology, National Center of Neurology and Psychiatry) |
David J. Burn(Institute of Neuroscience, Newcastle University) |
Recent advances in Parkinson disease: Hyperbole or hope? |
Ritsuko Hanajima(Department of Neurology, Kitasato University School of Medicine) |
Update on Tremor |
Yoshikazu Ugawa(Fukushima Medical University) |
What's Dystonic tremor? |
Kazuko Hasegawa(Department of Neurology, National Hospital Organization, Sagamihara National Hospital) |
Huntington's disease-update |
Room13(Kobe International Conference Center[Meeting Rooms 401+402] 4F) |
S-04 |
Biomarkers and progression of motor neuron disease |
Hirofumi Maruyama (Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences) / Masahisa Katsuno (Department of Neurology, Nagoya University Graduate School of Medicine) |
Hiroshi Mitsumoto(Eleanor and Lou Gehrig MDA/ALS Center, Department of Neurology, Columbia University Medical Center) |
Biomarkers of Disease Progression in ALS |
Naoko Takamatsu(Department of Neurology, Tokushima University Hospital) |
Recent advances in neuromuscular ultrasound in ALS |
Hirohisa Watanabe (Nagoya University, Brain and Mind Research Center/Department of Neurology, Nagoya University Graduate School of Medicine) |
Neural network disruption in amyotrophic lateral sclerosis and frontotemporal lobar degeneration |
Masahisa Katsuno (Department of Neurology, Nagoya University Graduate School of Medicine) |
Application of biomarkers for early-stage of spinal and bulbar muscular atrophy to clincal trials |
Yuta Iwai (Department of Neurology, Graduate School of Medicine, Chiba University) |
Axonal dysfunction precedes motor neuronal death in amyotrophic lateral sclerosis |
Room14(Kobe International Conference Center[Meeting Room 501] 5F) |
S-05 |
Neuro-oncology update---Roles of neurologists--- |
Hidehiro Mizusawa (National Center Hospital National Center of Neurology and Psychiatry) / Masatoyo Nishizawa (Department of Neurology, Clinical Neuroscience Branch Brain Research Institute, Niigata University) |
Wolfgang Grisold (Dept Neurol, Kaiser Franz Josef Hospital, Vienna, Austria) |
Neurooncology and Neurology |
Joon H. Uhm (Department of Neurology, Mayo Clinic) |
Neuro-oncology in the 21st century: Exciting advances in new and effective therapies |
Akitake Mukasa (Department of Neurosurgery, The University of Tokyo Hospital) |
A multidisciplinary approach to the treatment of brain tumors |
Nobuo Sanjo (Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences) |
Various neurological manifestations of lymphoma |
May 19 (Thursday) 8:00-10:00 |
Room7(Kobe Portopia Hotel[Kairaku 1] Main Building B1F) |
S-07 |
Disruption of glia-neuron assemblies in intractable neurological disorders |
Jun-ichi Kira (Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University) / Kazuhiro Ikenaka (Division of Neurobiology and Bioinformatics National Institute for Physiological Sciences) |
Kazuhiro Ikenaka (Division of Neurobiology and Bioinformatics National Institute for Physiological Sciences) |
Oligodendrocyte-neuron interaction in physiological and pathological states |
Jun-ichi Kira (Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University) |
Disruption of glia-neuron assemblies in an intractable neurological disorder |
Junichi Nabekura (National Institute for Physiological Science) |
Remodeling of Cortical Neuronal Circuits in vivo: Synapse-Microglia Interaction |
Hiroshi Nakanishi (Department of Aging Science and Pharmacology, Faculty of Dental Science, Kyushu University) |
Emerging roles of microglial cathepsins in intractable neurological disorders |
May 20 (Friday) 13:15-14:55 |
Room15(Kobe International Conference Center[Meeting Room502] 5F) |
S-16 |
Pathomechanisms and therapeutic intervention of abnormal excitability in the upper and lower motor neuron systems |
Hiroyuki Nodera (Department of Neurology, Tokushima Univeristy)/ Hugh Bostock (University College London) |
Hugh Bostock (Institute of Neurology, University College London) |
Muscle Excitability |
Cindy Shin-yi Lin (The University of New South Wales) |
Hyperexcitability and ALS: Past, present and future |
Hiroyuki Nodera (Department of Neurology, Tokushima Univeristy) |
Sodium channelopathy in disuse neuromyopathy |
Yusuke Osaki (Department of Neurology, Institute of Biomedical Sciences, Tokushima University Graduate School) |
Peripheral nerve excitability abnormality in spinocerebellar ataxia type 6 |
May 18 (Wednesday) 13:15-15:15 |
Room22(Kobe International Conference Center [Meeting Room505] 5F) |
IE-01 |
Multiple sclerosis |
William M. Carroll (Dept Neurology Sir Charles Gairdner Hospital/Western Australian Neuromuscular Research Institute/Centre for Neuromuscular and Neurological Disorders/University of Western Australia/Queen Elizabeth II Medical Centre) / Dede Gunawan (Department of Neurology, Padjadjaran University, Hasan Sadikin Hospital) |
William M. Carroll (Dept Neurology Sir Charles Gairdner Hospital/Western Australian Neuromuscular Research Institute/Centre for Neuromuscular and Neurological Disorders/University of Western Australia/Queen Elizabeth II Medical Centre) |
Recent advances in the treatment of multiple sclerosis. |
Saeed Abdulla. Bohlega(King Faisal Specialist Hospital & Research Centre) |
Epidemiology of Multiple Sclerosis in the Arab Region |
Jun-ichi Kira(Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University) |
Factors associated with susceptibility to and clinical features of multiple sclerosis in Japanese |
Ching-Piao Tsai(Neurological Institute, Taipei Veterans General Hospital and National Yang Ming University) |
Multiple Sclerosis in Taiwan, increased prevalence and changing clinical characteristics. |
Riadh Gouider(Neurology Department, Razi Hospital, Research Unit UR 12 SP 21, Tunis, Tunisia) |
Multiple Sclerosis in Africa |
May 19 (Thursday) 8:00-10:00 |
Room16(Kobe International Conference Center[Meeting Room403] 4F) |
IE-02 |
How to diagnose and treat MMN, an ALS mimic |
Austin Sumner (LSU Health Sciences Center) / Jean-Marc Leger (University Hospital Pitié-Salpêtrière and University Pierre et Marie Curie (Paris 6)) |
Austin J. Sumner (LSU Health Sciences Center) |
Multifocal Motor Neuropathy |
Hiroyuki Nodera (Department of Neurology, Tokushima University) |
Electrophysiology and imaging techniques for diagnosis of MMN |
Hugh Bostock (University College London) |
Nerve excitability studies and the pathophysiology of MMN: a reappraisal |
Jean-Marc Leger (University Hospital Pitié-Salpêtrière and University Pierre et Marie Curie (Paris 6)) |
Update in short and long-term therapy of mutifocal motor neuropathy |
May 19 (Thursday) 15:15-17:15 |
Room16(Kobe International Conference Center[Meeting Room403] 4F) |
IE-03 |
How to Manage Seizures |
Byung-In Lee (Department of Neurology, Inje University School of Medicine) / Kiyohito Terada (Department of Epileptology, Shizuoka Institute of Epilepsy and Neurological Disorders) |
Byung-In Lee (Department of Neurology, Inje University School of Medicine) |
When and What is Epilepsy? |
Kiyohito Terada (Department of Epileptology, Shizuoka Institute of Epilepsy and Neurological Disorders) |
Electroencephalography in Epilepsy |
Kheng-Seang Lim (University of Malaya, Malaysia) |
Imaging in Epilepsy |
Naoki Akamatsu (International University of Health and Welfare School of Health Sciences at Fukuoka) |
Treatment of seizures |
Akio Ikeda (Department of Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine) |
Uncommon, but important causes of epilepsy and seizure |
May 20 (Friday) 8:00-10:00 |
Room11(Kobe International Conference Center[International Conference Hall] 3・4F) |
IE-04 |
Movement Disorders Video Session |
Mitsutoshi Yamamoto(Takamatsu Neurology Clinic/Takamatsu Institute for Parkinson Disease) /Beomseok Jeon(Department of Neurology and Movement Disorder Center, Parkinson Study Group, Seoul National University Hospital) |
Beomseok Jeon (Department of Neurology and Movement Disorder Center, Parkinson Study Group, Seoul National University Hospital) |
Video vignettes in the diagnosis of Parkinson Disease |
Werner Poewe(Dept. of Neurology, Innsbruck Medical University) |
Non PD parkinsonism: a diagnostic challenge |
Raymond Lotilla Rosales(University of Santo Tomas Hospital, Manila, Philippines) |
Is this Spasticity, Dystonia, Both or Neither? |
Mitsutoshi Yamamoto (Takamatsu Neurology Clinic/Takamatsu Institute for Parkinson Disease) |
Hyperkinetic disorders |
Hiroshi Shibasaki(Kyoto University Graduate School of Medicine) |
Clinical Classification of Myoclonus |
Louis Tan (National Neuroscience Institute, Singapore) |
Paroxysmal Dyskinesias |
May 20 (Friday) 8:00-10:00 |
Room16(Kobe International Conference Center[Meeting Room403] 4F) |
IE-05 |
Spasticity: A Common But Under-Recognized Condition |
John Rothwell (Human Neurophysiology, UCL Institute of Neurology) /Kimiyoshi Arimura(Okatsu Neurology and Rehabilitation Hospital) |
John Rothwell (Human Neurophysiology, UCL Institute of Neurology) |
Physiology of post-stroke spasticity |
Leonard S.W.. Li (The Univeristy of Hong Kong) |
Management of Post-Stroke Spasticity |
Kimiyoshi Arimura (Okatsu Neurology and Rehabilitation Hospital) |
Practice of Botulinum Toxin Injection |
Yoshiyuki Sankai (Graduate School of Systems and Information Engineering, University of Tsukuba / Center for Cybernics Research, University of Tsukuba / Impulsing Paradigm Change through Disruptive Technologies (ImPACT) Program, JST / CYBERDYNE Inc) |
Dawn of Cybernic Neuro-rehabiliation: Combined Treatment with HAL and Botulinum Toxin Injection |
May 20 (Friday) 13:15-15:15 |
Room16(Kobe International Conference Center[Meeting Room403] 4F) |
IE-06 |
Emerging Therapies in ALS |
Hiroshi Mitsumoto(Eleanor and Lou Gehrig MDA/ALS Center, Department of Neurology, Columbia University Medical Center) /Koji Abe(Department of Neurology, Okayama University) |
Hiroshi Mitsumoto(Eleanor and Lou Gehrig MDA/ALS Center, Department of Neurology, Columbia University Medical Center) |
Randomized Clinical Trials (RCT) in ALS: A Turning Point |
Ken Ikeda(Department of Neurology, Toho University Omori Medical Center) |
Therapeutic Development using Wobbler Mouse, an Animal Model of ALS |
Koji Abe(Department of Neurology, Okayama University) |
Mechanism of ALS and the clinical neuroprotection in Japan |
Yuishin Izumi(Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University Graduate School) |
Clinical trials of ultra-high dose methylcobalamin in ALS |
Seung Hyun Kim(Hanyang University Hospital, Seoul, Korea) |
PHASE I/II TRIALS OF AUTOLOGOUS BM DERIVED STEM CELL THERAPY IN AMYOTROPHIC LATERAL SCLEROSIS |